Impact of Peripheral Ketolytic Deficiency on Hepatic Ketogenesis and Gluconeogenesis During the Transition to Birth
Overview
Affiliations
Preservation of bioenergetic homeostasis during the transition from the carbohydrate-laden fetal diet to the high fat, low carbohydrate neonatal diet requires inductions of hepatic fatty acid oxidation, gluconeogenesis, and ketogenesis. Mice with loss-of-function mutation in the extrahepatic mitochondrial enzyme CoA transferase (succinyl-CoA:3-oxoacid CoA transferase, SCOT, encoded by nuclear Oxct1) cannot terminally oxidize ketone bodies and develop lethal hyperketonemic hypoglycemia within 48 h of birth. Here we use this model to demonstrate that loss of ketone body oxidation, an exclusively extrahepatic process, disrupts hepatic intermediary metabolic homeostasis after high fat mother's milk is ingested. Livers of SCOT-knock-out (SCOT-KO) neonates induce the expression of the genes encoding peroxisome proliferator-activated receptor γ co-activator-1a (PGC-1α), phosphoenolpyruvate carboxykinase (PEPCK), pyruvate carboxylase, and glucose-6-phosphatase, and the neonate's pools of gluconeogenic alanine and lactate are each diminished by 50%. NMR-based quantitative fate mapping of (13)C-labeled substrates revealed that livers of SCOT-KO newborn mice synthesize glucose from exogenously administered pyruvate. However, the contribution of exogenous pyruvate to the tricarboxylic acid cycle as acetyl-CoA is increased in SCOT-KO livers and is associated with diminished terminal oxidation of fatty acids. After mother's milk provokes hyperketonemia, livers of SCOT-KO mice diminish de novo hepatic β-hydroxybutyrate synthesis by 90%. Disruption of β-hydroxybutyrate production increases hepatic NAD(+)/NADH ratios 3-fold, oxidizing redox potential in liver but not skeletal muscle. Together, these results indicate that peripheral ketone body oxidation prevents hypoglycemia and supports hepatic metabolic homeostasis, which is critical for the maintenance of glycemia during the adaptation to birth.
OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma.
Ding J, Li H, Liu Y, Xie Y, Yu J, Sun H Front Oncol. 2021; 11:698302.
PMID: 34804914 PMC: 8602561. DOI: 10.3389/fonc.2021.698302.
Arima Y, Nakagawa Y, Takeo T, Ishida T, Yamada T, Hino S Nat Metab. 2021; 3(2):196-210.
PMID: 33619377 DOI: 10.1038/s42255-021-00342-6.
A double-hit pre-eclampsia model results in sex-specific growth restriction patterns.
Stojanovska V, Dijkstra D, Vogtmann R, Gellhaus A, Scherjon S, Plosch T Dis Model Mech. 2019; 12(2).
PMID: 30683649 PMC: 6398487. DOI: 10.1242/dmm.035980.
Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism.
Rando G, Tan C, Khaled N, Montagner A, Leuenberger N, Bertrand-Michel J Elife. 2016; 5.
PMID: 27367842 PMC: 4963200. DOI: 10.7554/eLife.11853.
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Youm Y, Nguyen K, Grant R, Goldberg E, Bodogai M, Kim D Nat Med. 2015; 21(3):263-9.
PMID: 25686106 PMC: 4352123. DOI: 10.1038/nm.3804.